Our Rapid Testing solutions are designed to streamline biopharmaceutical development and manufacturing by providing fast, accurate, and regulatory-compliant results. Combining advanced NGS-based adventitious testing with ready-to-use residual detection kits, we empower researchers and manufacturers to accelerate product release, ensure biosafety, and maintain the highest standards of quality.
NGenius®: Our platform of NGS technology to deliver compliant, efficient, sensitive adventitious virus detection, accelerated biosafety release of biologics.
CelerQ® Detection Kit: Ready-to-use residuals detection kit for safe and reliable biopharmaceuticals production.
